{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:15:28Z","timestamp":1791472528840,"version":"4.3.4"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research\/Reviews in Mutation Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.mrrev.2019.03.005","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T11:53:52Z","timestamp":1553342032000},"page":"30-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["The worldwide mutational landscape of Berardinelli-Seip congenital lipodystrophy"],"prefix":"10.1016","volume":"781","author":[{"given":"Aquiles Sales","family":"Craveiro Sarmento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Capistrano","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josivan Gomes","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1zaro Batista","family":"de Azevedo Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Tain\u00e1","family":"Barbosa Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucymara Fassarella","family":"Agnez-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela Abbott","family":"Galv\u00e3o Ururahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julliane Tamara Ara\u00fajo","family":"de Melo Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrrev.2019.03.005_bib0005","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbalip.2008.12.014","article-title":"Lipodystrophies: disorders of adipose tissue biology","volume":"1791","author":"Garg","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0010","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1086\/313854","article-title":"HIV protease inhibitor-related lipodystrophy syndrome","volume":"30","author":"Carr","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/jcem-14-2-193","article-title":"An undiagnosed endocrinometabolic syndrome: report of 2 cases","volume":"14","author":"Berardinelli","year":"1954","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0025","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/adc.38.201.447","article-title":"Generalized lipodystrophy","volume":"38","author":"Seip","year":"1963","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2015.123","article-title":"Congenital generalized lipodystrophies--new insights into metabolic dysfunction","volume":"11","author":"Patni","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0035","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/ajmg.a.37115","article-title":"Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome","volume":"167","author":"Garg","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0040","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.biocel.2011.03.002","article-title":"Molecular mechanisms of human lipodystrophies: From adipocyte lipid droplet to oxidative stress and lipotoxicity","volume":"43","author":"Vigouroux","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0045","first-page":"8","article-title":"NCBI resource coordinators, database resources of the national center for biotechnology information","volume":"45","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0050","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS recommendations for the description of sequence variants: 2016 update","volume":"37","author":"den Dunnen","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0055","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1210\/jcem.84.9.6103","article-title":"A gene for congenital generalized lipodystrophy maps to human chromosome 9q34","volume":"84","author":"Garg","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0065","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg.39.10.722","article-title":"Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy","volume":"39","author":"Van Maldergem","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1043-2760(03)00078-X","article-title":"Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways","volume":"14","author":"Agarwal","year":"2003","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0075","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2741\/Leung","article-title":"The structure and functions of human lysophosphatidic acid acyltransferases","volume":"6","author":"Leung","year":"2001","journal-title":"Front. Biosci."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0080","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0005-2760(81)90274-5","article-title":"Topography of glycerolepid synthetic enzymes synthesis of phosphatidylserine, phosphatidylinositol and glycerolipid intermediates occurs on the cytoplasmic surface of rat liver microsomal vesicles","volume":"665","author":"Ballas","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0085","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00018-006-6016-8","article-title":"The life cycle of neutral lipids: synthesis, storage and degradation","volume":"63","author":"Athenstaedt","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.abb.2006.03.014","article-title":"Functional characterization of human 1-acylglycerol-3-phosphate acyltransferase isoform 8: cloning, tissue distribution, gene structure, and enzymatic activity","volume":"449","author":"Agarwal","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1677\/JOE-07-0027","article-title":"Functional characterization of human 1-acylglycerol-3-phosphate-O-acyltransferase isoform 9: cloning, tissue distribution, gene structure, and enzymatic activity","volume":"193","author":"Agarwal","year":"2007","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0100","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MOL.0b013e328354fcf4","article-title":"Lysophospholipid acyltransferases: 1-acylglycerol- 3-phosphate O-acyltransferases. From discovery to disease","volume":"23","author":"Agarwal","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0105","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1074\/jbc.M509612200","article-title":"A regulatory role for 1-acylglycerol-3-phosphate-O-acyltransferase 2 in adipocyte differentiation","volume":"281","author":"Gale","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cmet.2009.01.002","article-title":"Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-Deficient mouse model of congenital generalized lipodystrophy","volume":"9","author":"Cort\u00e9s","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0115","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.2337\/db12-0004","article-title":"Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations","volume":"61","author":"Subauste","year":"2012","journal-title":"Diabetes."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbrc.2004.12.024","article-title":"Enzymatic activity of naturally occurring 1-acylglycerol-3-phosphate-O- acyltransferase 2 mutants associated with congenital generalized lipodystrophy","volume":"327","author":"Haque","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0125","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/diabetes.52.6.1573","article-title":"Prevalence of mutations in AGPAT2 among human lipodystrophies","volume":"52","author":"Magr\u00e9","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0130","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1210\/jc.2003-030855","article-title":"Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy","volume":"88","author":"Agarwal","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0131797","article-title":"A frame-shift mutation in CAV1 is associated with a severe neonatal progeroid and lipodystrophy syndrome","volume":"10","author":"Schrauwen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0087173","article-title":"Divergent metabolic phenotype between two sisters with congenital generalized lipodystrophy due to double AGPAT2 homozygous mutations. A clinical, genetic and in silico study","volume":"9","author":"Cort\u00e9s","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0145","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/cge.12623","article-title":"Congenital generalized lipodystrophy: identification of novel variants and expansion of clinical spectrum","volume":"89","author":"Haghighi","year":"2015","journal-title":"Clin. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0150","first-page":"73","article-title":"Identification and characterisation of a novel pathogenic mutation in the human lipodystrophy gene AGPAT2: C48R: a novel mutation in AGPAT2","volume":"9","author":"Ramanathan","year":"2012","journal-title":"J. Inherit. Metab. Dis. Reports."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0155","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1210\/jc.2016-1005","article-title":"Natural history of congenital generalized lipodystrophy: a nationwide study from Turkey","volume":"101","author":"Akinci","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0160","first-page":"145","article-title":"Energy balance in congenital generalized lipodystrophy type I","volume":"82","author":"Taleban","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0165","doi-asserted-by":"crossref","DOI":"10.21767\/AMJ.2016.2640","article-title":"A novel variant of the Agpat2 mutation in generalized congenital lipodystrophy","volume":"09","author":"Shetty","year":"2016","journal-title":"Australas. Med. J."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00592-011-0308-7","article-title":"Description of an AGPAT2 pathologic allelic variant in a 54-year-old Caucasian woman with Berardinelli-Seip syndrome","volume":"48","author":"Pelosini","year":"2011","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.arcped.2008.10.005","article-title":"M.F. Ben Dridi, Lipodystrophie cong\u00e9nitale g\u00e9n\u00e9ralis\u00e9e de type 1 avec atteinte neurologique","volume":"16","author":"Ben Turkia","year":"2009","journal-title":"Arch. P\u00e9diatrie."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0180","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1210\/jc.2003-030485","article-title":"Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: Phenotype variability suggests important modifier effects","volume":"89","author":"Fu","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0185","first-page":"0","article-title":"Further delineation of AGPAT2 and BSCL2 related congenital generalized lipodystrophy in young infants","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0190","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ejmg.2012.07.011","article-title":"Identification of a novel nonsense mutation and a missense substitution in the AGPAT2 gene causing congenital generalized lipodystrophy type 1","volume":"55","author":"Haghighi","year":"2012","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ando.2012.11.008","article-title":"AGPAT2 gene mutation in a child with Berardinelli-Seip congenital lipodystrophy syndrome","volume":"74","author":"Rostami","year":"2013","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1210\/jc.2003-030415","article-title":"Mutations in the Seipin and AGPAT2 Genes Clustering in Consanguineous Families with Berardinelli-Seip Congenital Lipodystrophy from Two Separate Geographical Regions of Brazil","volume":"89","author":"Gomes","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1590\/S0004-27302011000100007","article-title":"S\u00edndrome de Berardinelli-Seip: descri\u00e7\u00e3o gen\u00e9tica e metab\u00f3lica de cinco pacientes","volume":"55","author":"Barra","year":"2011","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0210","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0215","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13","volume":"28","author":"Magr\u00e9","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ng1313","article-title":"Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome","volume":"36","author":"Windpassinger","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/brain\/awn216","article-title":"Seipinopathy: a novel endoplasmic reticulum stress-associated disease","volume":"132","author":"Ito","year":"2009","journal-title":"Brain."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/5207608","article-title":"Exploring seipin: from biochemistry to bioinformatics predictions","volume":"2018","author":"Craveiro Sarmento","year":"2018","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/B978-0-12-411619-1.00009-4","article-title":"Analyzing the functions and structure of the human lipodystrophy protein seipin","volume":"537","author":"Sim","year":"2014","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0240","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1083\/jcb.200711136","article-title":"Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast","volume":"180","author":"Fei","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0245","doi-asserted-by":"crossref","first-page":"20890","DOI":"10.1073\/pnas.0704154104","article-title":"The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology","volume":"104","author":"Szymanski","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.16582","article-title":"Seipin is required for converting nascent to mature lipid droplets","volume":"5","author":"Wang","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0255","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.15252\/embj.201695170","article-title":"Seipin regulates ER\u2013lipid droplet contacts and cargo delivery","volume":"35","author":"Salo","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molmet.2014.12.013","article-title":"Seipin oligomers can interact directly with AGPAT2 and lipin 1, physically scaffolding critical regulators of adipogenesis","volume":"4","author":"Talukder","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0265","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.celrep.2016.10.037","article-title":"SEIPIN regulates lipid droplet expansion and adipocyte development by modulating the activity of Glycerol-3-phosphate acyltransferase","volume":"17","author":"Pagac","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0270","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cmet.2014.03.028","article-title":"Seipin promotes adipose tissue fat storage through the ER Ca-ATPase SERCA","volume":"19","author":"Bi","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0275","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/hmg\/ddt444","article-title":"BSCL2\/seipin regulates adipogenesis through actin cytoskeleton remodelling","volume":"23","author":"Yang","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0280","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2337\/db08-0184","article-title":"The human lipodystrophy gene BSCL2\/Seipin may be essential for normal adipocyte differentiation","volume":"57","author":"Payne","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0285","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1210\/en.2009-0236","article-title":"The human lipodystrophy gene product Berardinelli-Seip congenital lipodystrophy 2\/seipin plays a key role in adipocyte differentiation","volume":"150","author":"Chen","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0290","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1399-0004.2002.610407.x","article-title":"Cardiomyopathy in congenital complete lipodystrophy","volume":"61","author":"Bhayana","year":"2002","journal-title":"Clin. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0295","first-page":"113","article-title":"A patient with congenital generalized lipodystrophy due to a novel mutation in BSCL2: indications for secondary mitochondrial dysfunction","volume":"4","author":"Jeninga","year":"2011","journal-title":"JIMD Rep."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0300","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1210\/jc.2003-030835","article-title":"Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes","volume":"88","author":"Simha","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0305","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4274\/jcrpe.3556","article-title":"Clinical and mutational features of three chinese children with congenital generalized lipodystrophy","volume":"9","author":"Su","year":"2017","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0310","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-07-0393","article-title":"Novel BSCL2 gene mutation E189X in Chinese congenital generalized lipodystrophy child with early onset diabetes mellitus","volume":"157","author":"Jin","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejmg.2008.10.006","article-title":"Severe cardiac phenotype of Berardinelli-Seip congenital lipodystrophy in an infant with homozygous E189X BSCL2 mutation","volume":"52","author":"Friguls","year":"2009","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0320","first-page":"1","article-title":"Congenital generalized lipodystrophy in Taiwan","volume":"118","author":"Hsu","year":"2018","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0325","first-page":"1","article-title":"High prevalence of Berardinelli-Seip Congenital Lipodystrophy in Rio Grande do Norte State, Northeast Brazil","volume":"9","author":"de A. Medeiros","year":"2017","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-016-0140-x","article-title":"Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy","volume":"8","author":"Lima","year":"2016","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0197784","article-title":"Nurses\u2019 knowledge about Berardinelli-Seip Congenital Lipodystrophy","volume":"13","author":"Candido Dantas","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0199052","article-title":"Causes of death in patients with Berardinelli- Seip congenital generalized lipodystrophy","volume":"13","author":"Lima","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0345","first-page":"440","article-title":"Berardinelli-Seip congenital lipodystrophy","volume":"43","author":"Mandal","year":"2006","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0350","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2265.2009.03532.x","article-title":"Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome","volume":"71","author":"Miranda","year":"2009","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0355","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1442-200X.2009.02863.x","article-title":"Two Japanese infants with congenital generalized lipodystrophy due to BSCL2 mutations","volume":"51","author":"Nishiyama","year":"2009","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0360","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2350-15-71","article-title":"Exome sequencing circumvents missing clinical data and identifies a BSCL2 mutation in congenital lipodystrophy","volume":"15","author":"Schuster","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-8-78","article-title":"Deletion mutation in BSCL2 gene underlies congenital generalized lipodystrophy in a Pakistani family","volume":"8","author":"Rahman","year":"2013","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0370","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.gene.2017.09.023","article-title":"Clinical and molecular characterization of two Chinese patients with Type 2 congenital generalized lipodystrophy","volume":"637","author":"Chen","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0375","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1607-551X(10)70094-2","article-title":"A Taiwanese boy with congenital generalized lipodystrophy caused by homozygous Ile262fs mutation in the BSCL2 gene","volume":"26","author":"Huang","year":"2010","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0380","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1210\/jc.2003-031211","article-title":"Gene and phenotype analysis of congenital generalized lipodystrophy in japanese: a novel homozygous nonsense mutation in seipin gene","volume":"89","author":"Ebihara","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0385","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1074\/jbc.M707890200","article-title":"A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization","volume":"283","author":"Liu","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0390","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1073\/pnas.93.1.131","article-title":"Identification, sequence, and expression of caveolin-2 defines a caveolin gene family","volume":"93","author":"Scherer","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0395","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1582-4934.2008.00295.x","article-title":"Caveolae structure and function","volume":"12","author":"Thomas","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0400","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1152\/physrev.00046.2003","article-title":"Role of caveolae and caveolins in health and disease","volume":"84","author":"Cohen","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0405","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-cellbio-100617-062737","article-title":"Caveolae: Structure, Function, and Relationship to Disease","volume":"34","author":"Parton","year":"2018","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0410","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2004-5-3-214","article-title":"The caveolin proteins","volume":"5","author":"Williams","year":"2004","journal-title":"Genome Biol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0415","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1073\/pnas.92.19.8655","article-title":"De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin","volume":"92","author":"Fra","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0420","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1126\/science.1062688","article-title":"Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice","volume":"293","author":"Drab","year":"2001","journal-title":"Science (80-.)"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0425","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with berardinelli-seip congenital lipodystrophy","volume":"93","author":"Kim","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0430","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1074\/jbc.M110970200","article-title":"Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities","volume":"277","author":"Razani","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0435","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-511X-7-3","article-title":"Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia","volume":"7","author":"Cao","year":"2008","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0440","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/CIRCGENETICS.111.961888","article-title":"Whole exome sequencing to identify a novel gene (Caveolin-1) associated with human pulmonary arterial hypertension","volume":"5","author":"Austin","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0445","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/tra.12452","article-title":"Characterization of a caveolin-1 mutation associated with both pulmonary arterial hypertension and congenital generalized lipodystrophy","volume":"17","author":"Han","year":"2016","journal-title":"Traffic"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0450","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2337\/diabetes.51.4.1291","article-title":"Molecular analysis of Berardinelli-Seip congenital lipodystrophy in Oman: evidence for multiple loci","volume":"51","author":"Heathcote","year":"2002","journal-title":"Diabetes."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0455","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajmg.10437","article-title":"Heterogeneity for congenital generalized lipodystrophy in seventeen patients from Oman","volume":"110","author":"Rajab","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0460","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0465","article-title":"Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes","volume":"383","author":"Aboulaich","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0470","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cell.2007.11.042","article-title":"PTRF-cavin, a conserved cytoplasmic protein required for caveola formation and function","volume":"132","author":"Hill","year":"2008","journal-title":"Cell."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0475","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cmet.2008.07.008","article-title":"Deletion of Cavin\/PTRF causes global loss of caveolae, dyslipidemia and glucose intolerance","volume":"8","author":"Liu","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0480","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/ajmg.a.33578","article-title":"Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations","volume":"152","author":"Shastry","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0485","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/ajmg.a.32457","article-title":"Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability","volume":"146","author":"Simha","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0162513","article-title":"PTRF\/Cavin-1 deficiency causes cardiac dysfunction accompanied by cardiomyocyte hypertrophy and cardiac fibrosis","volume":"11","author":"Taniguchi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.mrrev.2019.03.005_bib0495","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/S0002-9440(10)61168-6","article-title":"Caveolin-1\/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype","volume":"160","author":"Park","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000874","article-title":"Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations","volume":"6","author":"Rajab","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0505","first-page":"1","article-title":"Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report","volume":"28","author":"Takeyari","year":"2019","journal-title":"Clin. Pediatr. Endocrinol. Case Reports Clin. Investig. Off. J. Japanese Soc. Pediatr. Endocrinol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0510","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1210\/jc.2016-1086","article-title":"Maladaptative autophagy impairs adipose function in congenital generalized lipodystrophy due to cavin-1 deficiency","volume":"101","author":"Salle-Teyssi\u00e8res","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0515","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejmg.2016.05.001","article-title":"Spectrum of clinical manifestations in two young Turkish patients with congenital generalized lipodystrophy type 4","volume":"59","author":"Akinci","year":"2016","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0520","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2010.06.016","article-title":"A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4","volume":"101","author":"Dwianingsih","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0525","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejmg.2015.02.002","article-title":"Novel nonsense mutation in the PTRF gene underlies congenital generalized lipodystrophy in a consanguineous Saudi family","volume":"58","author":"Jelani","year":"2015","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0530","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.nmd.2013.02.005","article-title":"Congenital generalized lipodystrophy type 4 with muscular dystrophy: clinical and pathological manifestations in early childhood","volume":"23","author":"Murakami","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0535","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2350-14-89","article-title":"Novel PTRF mutation in a child with mild myopathy and very mild congenital lipodystrophy","volume":"14","author":"Ardissone","year":"2013","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0540","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/nar\/gkt1270","article-title":"Expression Atlas update--a database of gene and transcript expression from microarray- and sequencing-based functional genomics experiments","volume":"42","author":"Petryszak","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2018.01363","article-title":"A single complex Agpat2 allele in a patient with partial lipodystrophy","volume":"9","author":"Broekema","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0550","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/nar\/gku1221","article-title":"CDD: NCBI\u2019s conserved domain database","volume":"43","author":"Marchler-Bauer","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mrrev.2019.03.005_bib0555","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/nar\/gkt381","article-title":"Scalable web services for the PSIPRED protein analysis workbench","volume":"41","author":"Buchan","year":"2013","journal-title":"Nucleic Acids Res."}],"container-title":["Mutation Research\/Reviews in Mutation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138357421930002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138357421930002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:23:25Z","timestamp":1761301405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138357421930002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":111,"alternative-id":["S138357421930002X"],"URL":"https:\/\/doi.org\/10.1016\/j.mrrev.2019.03.005","relation":{},"ISSN":["1383-5742"],"issn-type":[{"value":"1383-5742","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The worldwide mutational landscape of Berardinelli-Seip congenital lipodystrophy","name":"articletitle","label":"Article Title"},{"value":"Mutation Research\/Reviews in Mutation Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrrev.2019.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}